BioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) has announced the appointment of seasoned technology executive Sharon Malka as an independent director of the company.
Malka brings extensive leadership experience to BioHarvest, with a background spanning international healthcare and technology companies.
Currently CEO of Dotz Nano, and a board member of Nasdaq-listed MediWound Limited, he has also held key roles, including CFO and CEO of MediWound and partner at Variance Economic Consulting.
"We are very pleased to announce the addition of Mr Malka to the BioHarvest board of directors," BioHarveest board chairman Dr Zaki Rakib said in a statement.
"His operational experience in advancing innovative technologies, and in structuring strategic transactions and major financing rounds, will be invaluable to BioHarvest in our current and future growth stages."
Ilan Sobel, BioHarvest CEO, added: "Sharon is a veteran capital markets and technology executive, whose perspective and experience will be very valuable as we scale our Botanical Synthesis technology and expand our operations.”
Malka expressed enthusiasm over the appointment, noting that the company has impressed him.
“With its leading-edge Botanical Synthesis technology, BioHarvest is poised for significant growth, and I am keen to contribute my experience and knowledge to support BioHarvest in its future success,” Malka said.